Key result
High-pressure stent deployment combined with ticlopidine and aspirin resulted in a 96% angiographic success rate and a low 0.5% rate of subacute stent thrombosis.
Why the study?
Does high-pressure coronary stent deployment combined with antiplatelet therapy reduce subacute thrombosis and bleeding complications while maintaining high success rates?
Observational (n=191)
No
Does high-pressure coronary stent deployment combined with antiplatelet therapy reduce subacute thrombosis and bleeding complications while maintaining high success rates?
High-pressure stent deployment combined with dual antiplatelet therapy (ticlopidine and aspirin) without oral anticoagulation yields high procedural success with acceptably low rates of subacute thrombosis and bleeding complications.
May support high-pressure stenting with dual antiplatelet therapy; leaves open need for randomized confirmation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Son et al. (1998) conducted an observational in Coronary artery disease (n=191). Coronary stenting with high-pressure balloon inflation and antiplatelet agents (ticlopidine and aspirin) was evaluated on Angiographic success rate. High-pressure stent deployment combined with ticlopidine and aspirin resulted in a 96% angiographic success rate and a low 0.5% rate of subacute stent thrombosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: